To evaluate whether the active ingredients in HQD can inhibit tumor growth, two malignant colon cancer cell lines, LoVo and HCT116, were cultured to assess the bioactivities of naringenin regarding anti-proliferation, effects on malignant behaviors, GOT1 expression, and glutamine metabolism. This evidence concerns the gene GOT1 and malignant colon neoplasm.